The UT Southwestern ADC proposes to study vascular risk factors in elderly individuals as important contributors to neurodegenerative dementias, and that such patients can be identified by their clinical and psychometric profile, neuroimaging studies and biochemical markers. Identification of vascular risk factors in patients evaluated in the Clinical Core that contribute to AD is our major focus. It is the objective of the ADC to study the contribution that cerebrovascular disease, particularly microvascular subcortical angiopathy, makes to the pathogenesis of AD and the cause of dementia. This research initiative was selected as it reflects the evolving interest of center investigators and represents a natural progression of our NIH R01-funded studies. Support for vascular factors will be obtained through prospectively following five cohorts: (a) Patients with Mild Cognitive Impairment, (b) Patients with Early Alzheimer's disease, (c) Patients with Non-AD Dementias; Pronto-Temporal Dementia, and Dementia with Psychotic Features, presumed Lewy Body Disease, (d) Controls for cohorts (a - c) representing subjects with no cognitive complaints, (e) Native-American cohort. Subjects with dementia and matched controls recruited at our Satellite Clinic in Talihina, Oklahoma. The ADC is a clinical site for the NIA Genetics Initiative. It is our plan to recruit families with AD throughout Texas. The ADC has applied to be a site for the NIA Neuroimaging Initiative. Quantitative neuropathologic evaluations for correlation with clinical and other research data will be obtained. Specific quantification of brain vascular alterations is proposed to correlate with the vascular markers obtained on clinical core patients for neuropathologic correlation. The Statistics and Data Management Core will provide statistical and database support for clinical and neuropathologic functions as well as web support for the Education Core. A new activity will be to support the computer storage and retrieval of MRI patient data. The Education and Information Transfer Core of the ADC plans an extensive program that publicizes ADC activities and educates physicians, healthcare professionals, families and caregivers about AD. """"""""The Genetics of AD"""""""" Continuing Medical Education course is planned for 2005. The Education Core has a major objective to help recruit and retain subjects for the research protocols of the ADC, including minority patients in Dallas and Native American patients in Talihina, OK. The ADC plans on continuing the recruitment of UTSW faculty to AD research through our Pilot Project and Friends of the ADC grants.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
5P30AG012300-14
Application #
7212078
Study Section
Special Emphasis Panel (ZAG1-ZIJ-8 (J1))
Program Officer
Phelps, Creighton H
Project Start
1997-04-01
Project End
2010-03-31
Budget Start
2007-05-15
Budget End
2008-03-31
Support Year
14
Fiscal Year
2007
Total Cost
$1,587,475
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Neurology
Type
Schools of Medicine
DUNS #
800771545
City
Dallas
State
TX
Country
United States
Zip Code
75390
Wang, Tingyan; Qiu, Robin G; Yu, Ming (2018) Predictive Modeling of the Progression of Alzheimer's Disease with Recurrent Neural Networks. Sci Rep 8:9161
Agogo, George O; Ramsey, Christine M; Gnjidic, Danijela et al. (2018) Longitudinal associations between different dementia diagnoses and medication use jointly accounting for dropout. Int Psychogeriatr 30:1477-1487
LoBue, Christian; Woon, Fu L; Rossetti, Heidi C et al. (2018) Traumatic brain injury history and progression from mild cognitive impairment to Alzheimer disease. Neuropsychology 32:401-409
Alosco, Michael L; Sugarman, Michael A; Besser, Lilah M et al. (2018) A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology. J Alzheimers Dis 63:1347-1360
Rosenberg, Roger N; Fu, Min; Lambracht-Washington, Doris (2018) Active full-length DNA A?42 immunization in 3xTg-AD mice reduces not only amyloid deposition but also tau pathology. Alzheimers Res Ther 10:115
Brent, Robert J (2018) Estimating the monetary benefits of medicare eligibility for reducing the symptoms of dementia. Appl Econ 50:6327-6340
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872
Tse, Kai-Hei; Cheng, Aifang; Ma, Fulin et al. (2018) DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's disease and dementia. Alzheimers Dement 14:664-679
Schaffert, Jeff; LoBue, Christian; White, Charles L et al. (2018) Traumatic brain injury history is associated with an earlier age of dementia onset in autopsy-confirmed Alzheimer's disease. Neuropsychology 32:410-416
Rosenberg, Roger N; Fu, Min; Lambracht-Washington, Doris (2018) Intradermal active full-length DNA A?42 immunization via electroporation leads to high anti-A? antibody levels in wild-type mice. J Neuroimmunol 322:15-25

Showing the most recent 10 out of 385 publications